by TractManager | Mar 3, 2021 | News
These Food and Drug Administration (FDA) approvals were recently announced:Nulibry (fosdenopterin)On February 26, 2021, the FDA approved a new drug application for Nulibry (fosdenopterin; Origin Biosciences Inc.) to reduce the risk of of mortality in patients with...
by TractManager | Mar 2, 2021 | Health Technology Assessment
Focus of the Report: This report focuses on venous sinus stenting (VSS) for treatment of idiopathic intracranial hypertension (IIH) that has failed to respond to available drug and conservative treatments.Technology Description: VSS is an endovascular procedure...
by TractManager | Mar 2, 2021 | News
The Food and Drug Administration (FDA) has announced a recall of specific lots of the Medtronic HVAD pump implant kits due to a possible delay or failure to start. The HeartWare Ventricular Assist Device (HVAD) pump implant kit is part of the HeartWare HVAD System,...
by TractManager | Mar 1, 2021 | News
The Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for the Janssen COVID-19 vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for use in...
by TractManager | Mar 1, 2021 | Emerging Technology Report
Amondys 45 (casimersen) is an intravenously administered antisense oligonucleotide indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon 45 skipping.If you have a Hayes...
Recent Comments